Malin Corporation | MLC - PE Price to Earnings


Malin Corporation reported 11.81 in PE Price to Earnings for its fiscal semester ending in June of 2023.





Pe Change Date
Akebia Therapeutics 1.63K 1.6K Dec/2025
ALKERMES 19.54 4.64 Dec/2025
Dianthus Therapeutics 3.8 1.53 Sep/2024
Eurofins Scientific SE 22.79 6.92 Dec/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
IQVIA Holdings 26.59 2.03 Dec/2025
Lonza 34.34 2.58 Dec/2025
Malin Corporation 11.81 0.72 Jun/2023
Moderna 27.22 14.51 Jun/2023
Organon & Co 3.75 0.87 Dec/2025
Ovoca Bio 1.83 3.29 Jun/2024
Revvity 49.87 16.58 Dec/2025
Tectonic Therapeutic 4.01 0.63 Mar/2024
Viatris 10.4 11.84 Sep/2025